Patents by Inventor Steven Connell

Steven Connell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220108347
    Abstract: A computer system for securely managing private data and providing user rewards for users selectively sharing the private data with third parties, having: (a) a central private data management system; and (b) a plurality of applications running on mobile or fixed-location devices that are configured to: (i) compile private data, (ii) permit the users to select elements of the compiled private data to be selectively shared with the third parties, wherein the central private data management system: (i) receives the selected elements of compiled private data, (ii) performs a demographic and psychographic analysis, (iii) writes the selected elements of compiled private data and the demographic and psychographic metadata into Blockchain blocks, (iv) sells keys to the Blockchain blocks to the third parties, and (v) distributes cryptocurrency to the user's mobile or fixed-location devices.
    Type: Application
    Filed: October 2, 2020
    Publication date: April 7, 2022
    Inventor: Steven Connell
  • Patent number: 9551721
    Abstract: The present invention provides for the identification of individuals having neurodegenerative diseases (ND). Peptoids recognized by Parkinson's Disease- and Alzheimer's Disease-specific antibodies are identified, allowing one to diagnose or predict ND in subjects.
    Type: Grant
    Filed: June 1, 2010
    Date of Patent: January 24, 2017
    Assignees: The Board of Regents of the University of Texas System, OPKO Health, Inc.
    Inventors: Muralidhar Reddy Moola, Dwight German, Steven Connell, Rosemary Wilson, Johnnie Wilson, Thomas Kodadek
  • Publication number: 20100303805
    Abstract: The present invention provides for the identification of individuals having neurodegenerative diseases (ND). Peptoids recognized by Parkinson's Disease- and Alzheimer's Disease-specific antibodies are identified, allowing one to diagnose or predict ND in subjects.
    Type: Application
    Filed: June 1, 2010
    Publication date: December 2, 2010
    Applicant: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Muralidhar Reddy Moola, Dwight German, Steven Connell, Rosemary Wilson, Johnnie Wilson, Thomas Kodadek